SuperworthArtelo Biosciences market cap ARTL
Share price times shares outstanding: what the whole company sells for, since 2019.
- Today, Oct 23, 2026
- $1.3M
- Highest close in our data
- $13.9M
- Feb 2021
Artelo Biosciences is worth $1.3M at the close on Oct 23, 2026, at $2.55 a share.
That is down 13% over the last year and down 78% over five years.
Its highest close in our data was $13.9M in Feb 2021.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $1.3M | $854.6K | $7.5M | +30% |
| 2025 | $1M | $898.6K | $4.4M | −12% |
| 2024 | $1.1M | $1M | $1.8M | −23% |
| 2023 | $1.5M | $1.2M | $3.1M | −46% |
| 2022 | $2.8M | $2.4M | $7.1M | −62% |
| 2021 | $7.3M | $5M | $13.9M | +99% |
| 2020 | $3.7M | $686.4K | $3.7M | +12% |
| 2019 | $3.3M | $2.1M | $3.9M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Artelo Biosciences' size, closest first, today.
| Company | Market cap |
|---|---|
| ARTLArtelo Biosciences | $1.3M |
| LNAILunai Bioworks | $1.5M |
| GNPXGenprex | $1.5M |
| GOVXGeoVax Labs | $1.5M |
| ONCOOnconetix | $1.7M |
| MTNBMatinas BioPharma | $1.7M |
| PPCBPropanc Biopharma | $1.8M |
| SILOSilo Pharma | $1.9M |
| OGENOragenics | $1.9M |
| KAPAKairos Pharma, LTD. | $1.9M |
| VBIOValion Bio | $834.3K |
| Peer median | $1.7M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Artelo Biosciences
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.